Chemoinformaics analysis of SOPHORADOCHROMENE
| Molecular Weight | 458.598 | nRot | 7 |
| Heavy Atom Molecular Weight | 424.326 | nRig | 21 |
| Exact Molecular Weight | 458.246 | nRing | 3 |
| Solubility: LogS | -3.483 | nHRing | 1 |
| Solubility: LogP | 8.139 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 75.979 |
| nHD | 2 | BPOL | 36.713 |
| QED | 0.262 |
| Synth | 3.315 |
| Natural Product Likeliness | 2.001 |
| NR-PPAR-gamma | 0.978 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.998 |
| Pgp-sub | 0.011 |
| HIA | 0.023 |
| CACO-2 | -5.007 |
| MDCK | 0.0000229 |
| BBB | 0.005 |
| PPB | 1.00754 |
| VDSS | 3.198 |
| FU | 0.0416052 |
| CYP1A2-inh | 0.673 |
| CYP1A2-sub | 0.177 |
| CYP2c19-inh | 0.94 |
| CYP2c19-sub | 0.086 |
| CYP2c9-inh | 0.91 |
| CYP2c9-sub | 0.928 |
| CYP2d6-inh | 0.894 |
| CYP2d6-sub | 0.558 |
| CYP3a4-inh | 0.551 |
| CYP3a4-sub | 0.176 |
| CL | 10.002 |
| T12 | 0.082 |
| hERG | 0.555 |
| Ames | 0.029 |
| ROA | 0.435 |
| SkinSen | 0.929 |
| Carcinogencity | 0.62 |
| EI | 0.139 |
| Respiratory | 0.885 |
| NR-Aromatase | 0.819 |
| Antiviral | Yes |
| Prediction | 0.899306 |